These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16955437)

  • 1. Abnormal neurotransmitter metabolite levels in Alzheimer patients with a delirium.
    van der Cammen TJ; Tiemeier H; Engelhart MJ; Fekkes D
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):838-43. PubMed ID: 16955437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
    Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
    Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
    Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
    Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
    Mitani H; Shirayama Y; Yamada T; Kawahara R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
    Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep in Alzheimer's disease and the sundown syndrome.
    Vitiello MV; Bliwise DL; Prinz PN
    Neurology; 1992 Jul; 42(7 Suppl 6):83-93; discussion 93-4. PubMed ID: 1630644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased midkine levels in sera from patients with Alzheimer's disease.
    Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease.
    Molina JA; Jiménez-Jiménez FJ; Vargas C; Gómez P; de Bustos F; Ortí-Pareja M; Tallón-Barranco A; Benito-León J; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1998; 105(2-3):279-86. PubMed ID: 9660106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
    Vermeiren Y; Le Bastard N; Van Hemelrijck A; Drinkenburg WH; Engelborghs S; De Deyn PP
    Alzheimers Dement; 2013 Sep; 9(5):488-98. PubMed ID: 23159046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and risk factors of delirium in demented and not demented elderly medical inpatients.
    Margiotta A; Bianchetti A; Ranieri P; Trabucchi M
    J Nutr Health Aging; 2006; 10(6):535-9. PubMed ID: 17183425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum VEGF levels are associated with Alzheimer's disease.
    Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
    Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
    J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease.
    Korolainen MA; Pirttilä T
    Acta Neurol Scand; 2009 Jan; 119(1):32-8. PubMed ID: 18547271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement.
    Nibuya M; Kanba S; Sekiya U; Suzuki E; Matsuo Y; Kinoshita N; Shintani F; Yagi G; Asai M
    Biol Psychiatry; 1995 Jul; 38(1):50-6. PubMed ID: 7548472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.
    Gerhardsson L; Lundh T; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2008; 25(6):508-15. PubMed ID: 18463412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.